Wide variation found in prices among Minnesota hospitals

Minnesota hospitals may be paid anywhere from $6,186 to $46,974 for a knee replacement, raising questions about why the same procedures can have such wildly different prices within the same state.

The report from the Minnesota Department of Health found similar variations for other procedures. A normal baby delivery can cost between $2,872 and $12,303. A C-section delivery ranged from a low of $4,693 to a high of $22,831.

While insured customers were likely insulated from the most drastic price differences, above average payments will drive up insurance premiums. If the patient is an increasingly prevalent high-deductible plan, they may be on the hook for a bigger bill if they don’t have an opportunity to compare hospital prices.

"Prices in most cases are really secretive in health care," Stefan Gildemeister, the state's health economist, told the Minneapolis Star-Tribune. "What that translates into is providers are able to charge higher prices than they would be able to do if the veil were lifted off those prices."

The study didn’t identify hospitals by name, a decision criticized by the healthcare purchasers represented by the Minnesota Health Action Group. The Minnesota Hospital Association, however, dismissed the report as “pretty sensationalized.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.